EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor neuroendocrino bien diferenciado de probable origen pulmonar con metástasis hepáticas y óseas tratado con 177Lu-DOTATATE: Reporte de caso

Elías José Leiva Parra, Pedro Paolo Sotelo-Jiménez, César García Vergara, Jesús De la Jara Cordero, Pamela Carrión Cabezas

Revista Médica Rebagliati · 29.03.2026 · 6 (1) · 28-34

DOI: 10.70106/rmr.v6i1.118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Médica Rebagliati, online erschienen am 29.03.2026. Verfasst von Elías José Leiva Parra und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroendocrine tumors (NETs) are uncommon neoplasms that may present with hepatic metastases while the primary tumor remains occult. We report the case of a 63-year-old man, with no significant medical history, who presented with a two-month history of abdominal pain in the right upper quadrant. Imaging revealed multiple hepatic nodules within a steatotic liver, with normal serum tumor markers. A liver biopsy identified a well-differentiated, grade 1 NET (Ki-67: 1%), with immunohistochemistry positive for synaptophysin, chromogranin, and CD56. Upper and lower gastrointestinal endoscopy, as well as capsule endoscopy, ruled out a gastrointestinal primary. A somatostatin-analogue PET/CT scan revealed a juxtahilar nodule in the left upper lobe and an ipsilateral hilar lymph node, both showing intense tracer uptake, along with hepatic and bone lesions. This led to a diagnosis of a well-differentiated, stage IV NET, likely of pulmonary origin. The patient underwent three cycles of peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE; the treatment was clinically well-tolerated, and a metabolic response was observed in the hepatic and bone lesions during follow-up. This case highlights the value of functional imaging and a multidisciplinary approach in managing metastatic NETs of unknown primary origin.

Zitieren

APA

Parra, E. J. L., Sotelo-Jiménez, P. P., Vergara, C. G., Cordero, J. D. L. J., & Cabezas, P. C. (2026). Tumor neuroendocrino bien diferenciado de probable origen pulmonar con metástasis hepáticas y óseas tratado con 177Lu-DOTATATE: Reporte de caso. Revista Médica Rebagliati, 6(1), 28-34. https://doi.org/10.70106/rmr.v6i1.118

Vancouver

Parra EJL, Sotelo-Jiménez PP, Vergara CG, Cordero JDLJ, Cabezas PC. Tumor neuroendocrino bien diferenciado de probable origen pulmonar con metástasis hepáticas y óseas tratado con 177Lu-DOTATATE: Reporte de caso. Revista Médica Rebagliati. 2026;6(1):28-34. doi:10.70106/rmr.v6i1.118

BibTeX
@article{Parra2026,
  author = {Parra, Elías José Leiva and Sotelo-Jiménez, Pedro Paolo and Vergara, César García and Cordero, Jesús De la Jara and Cabezas, Pamela Carrión},
  title = {Tumor neuroendocrino bien diferenciado de probable origen pulmonar con metástasis hepáticas y óseas tratado con 177Lu-DOTATATE: Reporte de caso},
  journal = {Revista Médica Rebagliati},
  year = {2026},
  volume = {6},
  number = {1},
  pages = {28--34},
  doi = {10.70106/rmr.v6i1.118}
}
Kostenlos starten →